1. Overview of results of peptide receptor radionuclide therapy with 3 radiolabeled somatostatin analogs;DJ Kwekkeboom;J Nucl Med,2005
2. NETTER-1 Phase III in Patients with Midgut Neuroendocrine Tumors Treated with 177Lu-DOTATATE: Efficacy and Safety Results;J Strosberg;J Nucl Med,2016
3. Dosimetry in Peptide radionuclide receptor therapy: a review;M Cremonesi;J Nucl Med,2006
4. Dosimetry for treatment with radiolabelled somatostatin analogues. A review;M Cremonesi;Q J Nucl Med Mol Imaging,2010
5. Nuclear medicine techniques for the imaging and treatment of neuroendocrine tumours;JJM Teunissen;Endocr Relat Cancer,2011